BridgeMD
Tests treatment safety and results for Cluster Headache
Official title Efficacy of Light Therapy in Treatment of Chronic Cluster Headache
ClinicalTrials.gov ID: NCT06540651
What this study is testing
- What it's testing
- Cluster headache is a primary headache. The chronic form of the disease is often difficult to treat.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female, of 18 years years old or more;
- Diagnosis of chronic cluster headache according to ICHD-3 criteria;
- Number of seizures during baseline equal to at least 24;
- Stability of prophylactic treatment for at least 1 month and commitment not to change it for the duration of the study;
- Patient affiliated to the French social security system.
You likely can't join if
- Contraindication to the use of light therapy: use of a photosensitizing treatment;
- Ophthalmological history: cataract, macular degeneration, glaucoma, retinitis pigmentosa;
- Patients who work at night;
- Other neurological, psychiatric or developmental pathologies considered incompatible with the study;
- Background treatment of cluster headache with melatonin;
- Persons protected by articles L1121-5, L1121-6 and L1121-8 of the French Public Health Code (pregnant or breast-feeding women, persons deprived of...
See the full eligibility criteria
- Male or female, of 18 years years old or more;
- Diagnosis of chronic cluster headache according to ICHD-3 criteria;
- Number of seizures during baseline equal to at least 24;
- Stability of prophylactic treatment for at least 1 month and commitment not to change it for the duration of the study;
- Patient affiliated to the French social security system.
- Patient who understands and speaks French correctly;
- Patient who has given free and informed written consent.
- Contraindication to the use of light therapy: use of a photosensitizing treatment;
- Ophthalmological history: cataract, macular degeneration, glaucoma, retinitis pigmentosa;
- Patients who work at night;
- Other neurological, psychiatric or developmental pathologies considered incompatible with the study;
- Background treatment of cluster headache with melatonin;
- Persons protected by articles L1121-5, L1121-6 and L1121-8 of the French Public Health Code (pregnant or breast-feeding women, persons deprived of their liberty by judicial decision, socially vulnerable persons, adults...
The study team makes the final eligibility decision.
Where it's taking place
- Marseille, France
- Nice, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marseille, France; Nice, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.